Pictet Asset Management
ETNB

Pictet Asset Management’s 89bio ETNB Stock Holding History

Pictet Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,075
Closed -$236K – 2094
2025
Q3 		$236K Sell
16,075
-4,019,315
-100% -$41M ﹤0.01% 1788
2025
Q2 		$39.6M Sell
4,035,390
-169,497
-4% -$1.4M 0.04% 354
2025
Q1 		$30.6M Buy
4,204,887
+1,197,853
+40% +$10.5M 0.03% 392
2024
Q4 		$23.5M Sell
3,007,034
-239,574
-7% -$1.97M 0.03% 461
2024
Q3 		$24M Sell
3,246,608
-355,977
-10% -$2.99M 0.03% 441
2024
Q2 		$28.9M Sell
3,602,585
-107,606
-3% -$961K 0.03% 384
2024
Q1 		$43.2M Sell
3,710,191
-847,489
-19% -$9.38M 0.05% 336
2023
Q4 		$50.9M Buy
4,557,680
+669,726
+17% +$6.16M 0.06% 306
2023
Q3 		$60M Buy
+3,887,954
New +$65.3M 0.07% 262

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pictet Asset Management's ETNB Position: Q4 2025 in Review

Pictet Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 16,075 shares — an estimated $236K sold.

Pictet Asset Management first reported a position in ETNB in Q3 2023 and held it in 9 quarters. The position peaked at $60M in Q3 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Pictet Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Pictet Asset Management sold 16,075 89bio shares in Q4 2025, an estimated $236K.
  • Pictet Asset Management first reported a position in 89bio in Q3 2023 and held it in 9 quarters.
  • Pictet Asset Management's 89bio position peaked at $60M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Pictet Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.